NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

50 hedge funds and large institutions have $51M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
1.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
13
Reduced
15
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
51
Millennium Management
New York
-$3.68M -20,966 Closed
EI
52
EAM Investors
California
-$756K -4,304 Closed
Two Sigma Advisers
53
Two Sigma Advisers
New York
-$216K -1,227 Closed
Marshall Wace
54
Marshall Wace
United Kingdom
-$120K -682 Closed
Two Sigma Investments
55
Two Sigma Investments
New York
-$100K -571 Closed
ECM
56
ExodusPoint Capital Management
New York
-$98K -560 Closed
DWA
57
Dorsey Wright & Associates
California
-$14K -79 Closed
CAM
58
ClariVest Asset Management
California
-$5K -27 Closed
SSB
59
Sandy Spring Bank
Maryland
-$4K -25 Closed
CLOS
60
Compagnie Lombard Odier SCmA
Switzerland
-$3K -14 Closed